Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
9.73
+0.27 (2.85%)
Aug 25, 2026, 1:57 PM EDT - Market open
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $97.67 million as of August 25, 2026. Its market cap has increased by 12.65% in one year.
Market Cap
97.67M
Enterprise Value
97.67M
1-Year Change
12.65%
Ranking
Category
Stock Price
$9.73
ChartMarket Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $97.67M, a decrease of -54.64%. That is a compound annual growth rate of -6.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 97.67M | -25.10% |
| Dec 31, 2025 | 130.40M | 70.01% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
| Oct 16, 2014 | 215.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 101.91M |
| PolyPid | 101.25M |
| Fortress Biotech | 97.72M |
| Kalaris Therapeutics | 97.60M |
| Adicet Bio | 95.80M |
| Acrivon Therapeutics | 94.28M |
| Cognition Therapeutics | 93.62M |
| Polaryx Therapeutics | 93.21M |